Denali Therapeutics Inc. (DNLI) fell -7.44% or -1.59 to $19.78. It is near to 234378 shares traded, which is 48.59% compare to the average total volume 482398. The market cap of DNLI is $1.88 billion. The year to date change is 3.11%. The 52 week price range is from $12.32 to $25.79. Price of DNLI have changed 1.39% during last week. It have changed 10.08% over last month, 48.44% over last 3 months, 57.31% over last 6 months and 3.31% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for DNLI is 19.60. It is -0.91% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for DNLI is 18.06. It is -8.70% below current price. The 52-week High is 25.79. It is 30.38% from the current price. The 52-week Low is 12.32. It is -37.71% from current price.
There are some statistics of DNLI. It is has market cap $1.88 billion. The share outstanding is 94.96 million. The average volume is 482398. The percent of top 15 Institution holding is 90.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of DNLI is -41.77%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of DNLI is -36.21%.